#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biotinidase deficiency Kaposi's sarcoma Insulinoma Transitional cell cancer of the renal pelvis and ureter Alagille syndrome Paraneoplastic neurological syndrome Pulmonary alveolar haemorrhage Oesophageal adenocarcinoma Deafness neurosensory PIK3CA related overgrowth spectrum Univentricular heart Netherton's syndrome Astrocytoma Activated PI3 kinase delta syndrome Chronic myelomonocytic leukaemia More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Life with Disease Angiosarcoma – Trials in Disease Glycogen storage disease type II – Trials in Disease Primary immunodeficiency syndrome – Trials in Disease Leiomyosarcoma – Basic Information Cystic fibrosis lung – Life with Disease Alport’s syndrome – Trials in Disease Pulmonary fibrosis – Life with Disease Friedreich’s ataxia – Diagnostics Idiopathic inflammatory myopathy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bexmarilimab Alglucosidase Alfa Protrans Tipiracil Hydrochloride Chlorpromazine Oxybuprocaine Fitusiran Rbd5044 Sodium Evolocumab Tacrolimus Bisoprolol Fumarate Pegfilgrastim KETOROLAC TROMETAMOL Anb032 Paracetamol Ph. Eur. Potassium Chloride Ads-013 Risedronate Sodium Dextromethorphan Hydrobromide Brimonidine Tartrate More therapies…

    Learn about Your Condition

    Oesophagectomy Rett syndrome Bacterial infection Drug eruption Lung transplant Behcet's syndrome Systemic lupus erythematosus Cachexia Breast cancer stage IV Gaucher's disease type I Laryngeal cancer stage II Crohn's disease Meningioma malignant Supraventricular tachycardia Gastrointestinal disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Oxytocin Nasal Spray for Reducing Cravings and Preventing Relapse in Adults with Substance Use Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Substance use disorder
    Investigated Drugs:
    • Oxytocin
    Italy

  • Microdosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands

  • Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    • Major depression
    Investigated Drugs:
    • Magnesium Stearate
    • Daridorexant
    • Cellulose, Microcrystalline
    Spain

  • A study to evaluate the effects of rifaximin in patients with opioid use disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Substance use disorder
    Investigated Drugs:
    • Rifaximin
    Italy

  • A study to evaluate the safety and effectiveness of azetukalner in patients with bipolar depression

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Azetukalner
    Bulgaria France Germany Spain

  • A study to evaluate the effect of sodium oxybate on sleep quality in adult patients in intensive care units

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Sleep disorder
    Investigated Drugs:
    • Sodium Oxybate
    France
Previous Page
1 … 21 22 23 24 25 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!